Pulmonary Fibrosis News Community › Forums › Treatments and Science › Ofev (Nintedanib) › Real World Study Finds IPF Patients with Poor Lung Function Before Starting Ofev Most Likely to Stop Use

  • Real World Study Finds IPF Patients with Poor Lung Function Before Starting Ofev Most Likely to Stop Use

    Posted by Community Member on November 19, 2018 at 5:11 pm

    Real-world U.K. data found poorer lung function at the start of Ofev treatment, plus older age, marked patients with IPF who stopped using it. Click here to read more.

    What do you think about this study and its findings?

    replied 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.